Lynn Tetrault sells 5,307 NEO shares under 10b5-1 (NASDAQ: NEO)

Rhea-AI Filing Summary

NeoGenomics (NEO) affiliate sale reported. Lynn Tetrault executed a 10b5-1 sale of 5,307 shares of Common Stock on 06/09/2026. The filing lists proceeds of $59,905.42. The record also shows 5,307 Restricted Stock Units dated 06/01/2026.

Insights

Corporate Governance Analyst

Routine affiliate sale under a 10b5-1 plan; limited immediate governance signal.

The filing shows an affiliate sale of $59,905.42 via 5,307 shares on 06/09/2026, executed under a 10b5-1 plan. Such programmed plans are typically pre-arranged and reduce the informational value of timing.

Watch for subsequent Form 4/144 filings that might show additional sales or remaining holdings; the excerpt lists matching 5,307 RSUs dated 06/01/2026, which may explain the source of shares.

Key Figures

Shares sold: 5,307 shares Proceeds reported: $59,905.42 RSUs listed: 5,307 Restricted Stock Units

3 metrics

Shares sold 5,307 shares Sale date <date>06/09/2026</date>

Proceeds reported $59,905.42 Proceeds associated with the 06/09/2026 sale

RSUs listed 5,307 Restricted Stock Units RSU date <date>06/01/2026</date>

Key Terms

Form 144, 10b5-1, Restricted Stock Units

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for LYNN TETRAULT"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Common | 06/01/2026 | Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/15/2026 - 04:37 PM Accepted by SEC EDGAR 06/15/2026 - 04:36 PM Learn about SEC filing dates

FAQ

What did the NEO Form 144 disclose about Lynn Tetrault's sale?

The Form 144 reports a 10b5-1 sale of 5,307 shares on 06/09/2026. The filing lists proceeds of $59,905.42 and references 5,307 Restricted Stock Units dated 06/01/2026, suggesting the shares came from those RSUs.

Was the sale by Lynn Tetrault part of a pre-arranged trading plan (10b5-1)?

Yes—the filing references a 10b5-1 sale. That indicates the transaction was executed under a pre-established plan, which typically schedules sales in advance rather than as discretionary open-market trades.

How many shares and what proceeds are listed in the NEO filing?

The filing lists 5,307 shares and proceeds of $59,905.42. These figures appear alongside sale and RSU dates: shares/RSUs dated 06/01/2026 and the sale executed on 06/09/2026.

Do these Form 144 details change NeoGenomics' outstanding share count or capital structure?

No such impact is stated in the excerpt. The filing documents an affiliate sale and RSU issuance; it does not report changes to outstanding share totals or company capital structure in the provided text.

Where can I see follow-up filings related to this transaction for NEO?

Look for subsequent Form 4 or amended Form 144 filings. Those filings would show post-transaction holdings, additional sales, or clarifying footnotes about beneficial ownership and whether shares were issued, exercised, or transferred.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5307	59173.05	130211780	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Restricted Stock Units	Issuer			5307	06/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for LYNN TETRAULT 9490 NeoGenomics Way Fort Myers FL 33912	Common	06/09/2026	5307	59905.42

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)